Literature DB >> 15516983

Dickkopf-3/REIC functions as a suppressor gene of tumor growth.

Sen-Yung Hsieh1, Pei-Shan Hsieh, Cheng-Tang Chiu, Wai-Ying Chen.   

Abstract

To identify putative tumor suppressor genes in hepatocarcinogenesis, we combined the representational difference analysis and reverse northern blot identifying downregulated genes in human hepatoma tissues. One of them was Dkk-3/REIC. Dkk-3/REIC was downregulated in 11 out of the 20 human hepatoma tissues as compared to their counterparts of noncancerous liver tissues by northern blot analysis. It was also downregulated in 29 out of 48 human cancer samples including the kidney, urinary bladder, prostate, pancreas and lung cancers. Its gene product, Dkk-3/REIC, was found to be N-glycosylated and have two isoforms, the 55 kDa in the cytosol and 50 kDa secreted in the medium. Ectopic expression of Dkk-3/REIC in HeLa, Hep3B and Huh 7 cells led to suppression of cell growth, which was primarily attributable to induction of cell apoptosis. The suppression phenomenon was found to be cell-type related (most prominent in HeLa and least in Hep3B cells) and cell-density dependent (attenuated as the cell density increased). Transduction of Dkk-3/REIC into HeLa and Hep3B cells caused suppression on colony formation in vitro and reduced tumor growth rate in inoculated athymic nude mice. In conclusion, these data indicate that Dkk-3/REIC functions as a suppressor for human tumor growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516983     DOI: 10.1038/sj.onc.1208138

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

1.  Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer.

Authors:  An You; Emmanouil Fokas; Lin-Fang Wang; Haitao He; Beate Kleb; Dieter Niederacher; Rita Engenhart-Cabillic; Han-Xiang An
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-09       Impact factor: 4.553

2.  Analysis of Dickkopf3 interactions with Wnt signaling receptors.

Authors:  Rei E I Nakamura; Abigail S Hackam
Journal:  Growth Factors       Date:  2010-08       Impact factor: 2.511

3.  Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.

Authors:  Maria Papatriantafyllou; Gerhard Moldenhauer; Julia Ludwig; Anna Tafuri; Natalio Garbi; Gorana Hollmann; Günter Küblbeck; Alexandra Klevenz; Sabine Schmitt; Georg Pougialis; Christof Niehrs; Hermann-Josef Gröne; Gunter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

4.  Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Authors:  Thanh H Dellinger; Kestutis Planutis; Danielle D Jandial; Ramez N Eskander; Micaela E Martinez; Xiaolin Zi; Bradley J Monk; Randall F Holcombe
Journal:  Gynecol Oncol       Date:  2012-04-30       Impact factor: 5.482

5.  Wnt antagonist gene polymorphisms and renal cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koichi Nakajima; Nobuyuki Kikuno; Soichiro Yamamura; Kazumori Kawakami; Yutaka Suehiro; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

6.  Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.

Authors:  Liran Zhou; Hongmei Husted; Todd Moore; Mason Lu; Defeng Deng; Yan Liu; Vijaya Ramachandran; Thiruvengadam Arumugam; Christof Niehrs; Huamin Wang; Paul Chiao; Jianhua Ling; Michael A Curran; Anirban Maitra; Mien-Chie Hung; Jeffrey E Lee; Craig D Logsdon; Rosa F Hwang
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

7.  Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.

Authors:  Yu-Mei Gu; Yi-Hui Ma; Wu-Gan Zhao; Jie Chen
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

8.  Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.

Authors:  F Leung; A Dimitromanolakis; H Kobayashi; E P Diamandis; V Kulasingam
Journal:  Clin Biochem       Date:  2013-03-23       Impact factor: 3.281

9.  Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics.

Authors:  Anna Prudova; Ulrich auf dem Keller; Georgina S Butler; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2010-03-20       Impact factor: 5.911

10.  Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Authors:  Rute B Marques; Natasja F Dits; Sigrun Erkens-Schulze; Wytske M van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.